These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17638739)

  • 1. Cutaneous T-cell lymphoid dyscrasia: a unifying term for idiopathic chronic dermatoses with persistent T-cell clones.
    Guitart J; Magro C
    Arch Dermatol; 2007 Jul; 143(7):921-32. PubMed ID: 17638739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
    Kempf W; Dummer R; Burg G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma.
    Koh HK; Charif M; Weinstock MA
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):943-60. PubMed ID: 8522490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature.
    Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE
    J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The applicability of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for cutaneous T-cell lymphoma.
    Khalil SH; Hamadah IR
    Saudi Med J; 2006 Jul; 27(7):951-4. PubMed ID: 16830010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clonality in cutaneous T cell lymphoma and associated diseases.
    Wood GS
    Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
    Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
    Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-associated reversible granulomatous T cell dyscrasia: a distinct subset of the interstitial granulomatous drug reaction.
    Magro CM; Cruz-Inigo AE; Votava H; Jacobs M; Wolfe D; Crowson AN
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():96-111. PubMed ID: 20482682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell primary cutaneous lymphomas. A clinicopathological and immunohistochemical study.
    Caruntu ID; Mardari V; Radulescu D; Chirana A; Cozma L; Taranu T; Dobrescu G
    Pol J Pathol; 2007; 58(4):259-65. PubMed ID: 18459460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in the management of the cutaneous T cell lymphomas.
    Zic JA
    Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: cutaneous T-cell lymphoma (CTCL)--classification, staging, and treatment options.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():3-12. PubMed ID: 18405180
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum preceding the onset of cutaneous T-cell lymphoma.
    Hussain W; Layton A; Baxter K; Scott D
    Clin Exp Dermatol; 2006 Mar; 31(2):284-6. PubMed ID: 16487114
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.
    Kinney MC; Jones D
    Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal subcutaneous panniculitis-like T-cell lymphoma gamma/delta subtype (cutaneous gamma/delta T-cell lymphoma): report of a case and review of the literature.
    Kao GF; Resh B; McMahon C; Gojo I; Sun CC; Phillips D; Zhao XF
    Am J Dermatopathol; 2008 Dec; 30(6):593-9. PubMed ID: 19033937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SHP-1 tyrosine phosphatase expression correlates with the advanced stages of cutaneous T-cell lymphoma.
    Witkiewicz A; Raghunath P; Wasik A; Junkins-Hopkins JM; Jones D; Zhang Q; Odum N; Wasik MA
    Hum Pathol; 2007 Mar; 38(3):462-7. PubMed ID: 17239936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of TCR-beta clonality in a diverse group of cutaneous T-Cell infiltrates.
    Plaza JA; Morrison C; Magro CM
    J Cutan Pathol; 2008 Apr; 35(4):358-65. PubMed ID: 17976210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of cutaneous T-cell lymphoma.
    Burg G; Dummer R; Dommann S; Nestle F; Nickoloff B
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):961-95. PubMed ID: 8522491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.